PROSPECTS FOR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE FIRST LINE OF THERAPY FOR AGGRESSIVE NON-HODGKIN’S LYMPHOMAS. Вопр. онкол. 2017, 63 (2), 326-328. https://doi.org/10.37469/0507-3758-2017-63-2-326-328.